Global Group B Streptococcus (GBS) Infection Treatment Market Growth (Status and Outlook) 2022-2028
- LP 4858354
- 89 Pages
- February 2022
- Medical Devices
The United States Group B Streptococcus (GBS) Infection Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Group B Streptococcus (GBS) Infection Treatment market, reaching US$ million by the year 2028. As for the Europe Group B Streptococcus (GBS) Infection Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Group B Streptococcus (GBS) Infection Treatment players cover Pfizer Inc., Alopexx Enterprises, LLC, Wellstat Vaccines LLC, and Minervax ApS, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Group B Streptococcus (GBS) Infection Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Prenatal-onset Gbs Disease
Early-onset Gbs Disease
Late-onset Gbs Disease
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer Inc.
Alopexx Enterprises, LLC
Wellstat Vaccines LLC
Minervax ApS
Novartis
GlaxoSmithKline
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size 2017-2028
2.1.2 Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Group B Streptococcus (GBS) Infection Treatment Segment by Type
2.2.1 Prenatal-onset Gbs Disease
2.2.2 Early-onset Gbs Disease
2.2.3 Late-onset Gbs Disease
2.3 Group B Streptococcus (GBS) Infection Treatment Market Size by Type
2.3.1 Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2017-2022)
2.4 Group B Streptococcus (GBS) Infection Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Group B Streptococcus (GBS) Infection Treatment Market Size by Application
2.5.1 Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2017-2022)
3 Group B Streptococcus (GBS) Infection Treatment Market Size by Player
3.1 Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Players
3.1.1 Global Group B Streptococcus (GBS) Infection Treatment Revenue by Players (2020-2022)
3.1.2 Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Group B Streptococcus (GBS) Infection Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Group B Streptococcus (GBS) Infection Treatment by Regions
4.1 Group B Streptococcus (GBS) Infection Treatment Market Size by Regions (2017-2022)
4.2 Americas Group B Streptococcus (GBS) Infection Treatment Market Size Growth (2017-2022)
4.3 APAC Group B Streptococcus (GBS) Infection Treatment Market Size Growth (2017-2022)
4.4 Europe Group B Streptococcus (GBS) Infection Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2017-2022)
5.2 Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2017-2022)
5.3 Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2017-2022)
6.2 APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2017-2022)
6.3 APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Group B Streptococcus (GBS) Infection Treatment by Country (2017-2022)
7.2 Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2017-2022)
7.3 Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment by Region (2017-2022)
8.2 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.1 Global Group B Streptococcus (GBS) Infection Treatment Forecast by Regions (2023-2028)
10.1.1 Global Group B Streptococcus (GBS) Infection Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Group B Streptococcus (GBS) Infection Treatment Forecast
10.1.3 APAC Group B Streptococcus (GBS) Infection Treatment Forecast
10.1.4 Europe Group B Streptococcus (GBS) Infection Treatment Forecast
10.1.5 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Forecast
10.2 Americas Group B Streptococcus (GBS) Infection Treatment Forecast by Country (2023-2028)
10.2.1 United States Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.2.2 Canada Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.2.3 Mexico Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.2.4 Brazil Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3 APAC Group B Streptococcus (GBS) Infection Treatment Forecast by Region (2023-2028)
10.3.1 China Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.2 Japan Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.3 Korea Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.4 Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.5 India Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.6 Australia Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4 Europe Group B Streptococcus (GBS) Infection Treatment Forecast by Country (2023-2028)
10.4.1 Germany Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4.2 France Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4.3 UK Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4.4 Italy Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4.5 Russia Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5.2 South Africa Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5.3 Israel Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5.4 Turkey Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5.5 GCC Countries Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.6 Global Group B Streptococcus (GBS) Infection Treatment Forecast by Type (2023-2028)
10.7 Global Group B Streptococcus (GBS) Infection Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Information
11.1.2 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Offered
11.1.3 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc. Latest Developments
11.2 Alopexx Enterprises, LLC
11.2.1 Alopexx Enterprises, LLC Company Information
11.2.2 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Offered
11.2.3 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Alopexx Enterprises, LLC Main Business Overview
11.2.5 Alopexx Enterprises, LLC Latest Developments
11.3 Wellstat Vaccines LLC
11.3.1 Wellstat Vaccines LLC Company Information
11.3.2 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Offered
11.3.3 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Wellstat Vaccines LLC Main Business Overview
11.3.5 Wellstat Vaccines LLC Latest Developments
11.4 Minervax ApS
11.4.1 Minervax ApS Company Information
11.4.2 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Offered
11.4.3 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Minervax ApS Main Business Overview
11.4.5 Minervax ApS Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Group B Streptococcus (GBS) Infection Treatment Product Offered
11.5.3 Novartis Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Offered
11.6.3 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 GlaxoSmithKline Main Business Overview
11.6.5 GlaxoSmithKline Latest Developments
12 Research Findings and Conclusion
Table 1. Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Prenatal-onset Gbs Disease
Table 3. Major Players of Early-onset Gbs Disease
Table 4. Major Players of Late-onset Gbs Disease
Table 5. Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2017-2022)
Table 8. Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2017-2022)
Table 11. Global Group B Streptococcus (GBS) Infection Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Player (2020-2022)
Table 13. Group B Streptococcus (GBS) Infection Treatment Key Players Head office and Products Offered
Table 14. Group B Streptococcus (GBS) Infection Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Regions (2017-2022)
Table 19. Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Country (2017-2022)
Table 21. Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2017-2022)
Table 23. Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2017-2022)
Table 25. APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region (2017-2022)
Table 27. APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2017-2022)
Table 29. APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2017-2022)
Table 31. Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Country (2017-2022)
Table 33. Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2017-2022)
Table 35. Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Group B Streptococcus (GBS) Infection Treatment
Table 44. Key Market Challenges & Risks of Group B Streptococcus (GBS) Infection Treatment
Table 45. Key Industry Trends of Group B Streptococcus (GBS) Infection Treatment
Table 46. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 52. Pfizer Inc. Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 53. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 54. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Pfizer Inc. Main Business
Table 56. Pfizer Inc. Latest Developments
Table 57. Alopexx Enterprises, LLC Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 58. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 59. Alopexx Enterprises, LLC Main Business
Table 60. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Alopexx Enterprises, LLC Latest Developments
Table 62. Wellstat Vaccines LLC Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 63. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 64. Wellstat Vaccines LLC Main Business
Table 65. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Wellstat Vaccines LLC Latest Developments
Table 67. Minervax ApS Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 68. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 69. Minervax ApS Main Business
Table 70. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Minervax ApS Latest Developments
Table 72. Novartis Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 73. Novartis Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 74. Novartis Main Business
Table 75. Novartis Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Novartis Latest Developments
Table 77. GlaxoSmithKline Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 78. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 79. GlaxoSmithKline Main Business
Table 80. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. GlaxoSmithKline Latest Developments
List of Figures
Figure 1. Group B Streptococcus (GBS) Infection Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type in 2021
Figure 7. Group B Streptococcus (GBS) Infection Treatment in Hospital Pharmacies
Figure 8. Global Group B Streptococcus (GBS) Infection Treatment Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. Group B Streptococcus (GBS) Infection Treatment in Retail Pharmacies
Figure 10. Global Group B Streptococcus (GBS) Infection Treatment Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 11. Group B Streptococcus (GBS) Infection Treatment in Online Pharmacies
Figure 12. Global Group B Streptococcus (GBS) Infection Treatment Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 13. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application in 2021
Figure 14. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Player in 2021
Figure 15. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Group B Streptococcus (GBS) Infection Treatment Market Size 2017-2022 ($ Millions)
Figure 17. APAC Group B Streptococcus (GBS) Infection Treatment Market Size 2017-2022 ($ Millions)
Figure 18. Europe Group B Streptococcus (GBS) Infection Treatment Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Americas Group B Streptococcus (GBS) Infection Treatment Value Market Share by Country in 2021
Figure 21. Americas Group B Streptococcus (GBS) Infection Treatment Consumption Market Share by Type in 2021
Figure 22. Americas Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application in 2021
Figure 23. United States Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region in 2021
Figure 28. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application in 2021
Figure 29. China Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Country in 2021
Figure 36. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type in 2021
Figure 37. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application in 2021
Figure 38. Germany Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application in 2021
Figure 46. Egypt Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 52. APAC Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 53. Europe Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 55. United States Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Canada Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 59. China Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Japan Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Korea Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 63. India Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Australia Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Germany Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 66. France Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 67. UK Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Italy Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Russia Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Spain Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Israel Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Group B Streptococcus (GBS) Infection Treatment Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
